⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RXRX News
Recursion Pharmaceuticals, Inc. Class A Common Stock
Recursion to Present at 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
RXRX
Menlo Ventures Announces Promotion of Deborah Carrillo to Partner
globenewswire.com
ROKU
UBER
RXRX
Platform Technologies Drive $211B Surge in Precision Cancer Treatment
prnewswire.com
GTBP
ERAS
FHTX
OABI
RXRX
Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks
globenewswire.com
RXRX
Recursion Announces Webinar For Upcoming Clinical Data Readout on the TUPELO Phase 1b/2 Trial of REC-4881 in Familial Adenomatous Polyposis on December 8, 2025
globenewswire.com
RXRX
IMS25 versammelt globale Vordenker in Riad: Rekordbeteiligung und wichtige Ankündigungen prägen die Zukunft der MICE-Branche USA - Deutsch USA - English Middle East - English BRAZIL - Portuguese MEXICO - Spanish
prnewswire.com
MCH
OAKVF
CMPS
HONEF
RXRX
IFX
MCK
CLAR
GL
DMGE
Recursion Reports Third Quarter 2025 Financial Results and Provides Business Update
globenewswire.com
RXRX
Recursion Announces CEO Transition Plan to Drive Next Phase of Growth
globenewswire.com
RXRX
Recursion to Participate in Upcoming Investor Conferences
globenewswire.com
RXRX
Recursion to Report Third Quarter 2025 Business Updates and Financial Results on November 5th
globenewswire.com
RXRX